Summary
In recent news, genetics testing giant, 23andMe, has informed several of its users about a security breach concerning its "DNA Relatives" feature. This feature, which enables users globally to compare and share ancestry data, was infiltrated, potentially exposing sensitive information like relationship labels, ancestry reports, matching DNA segments, and more.
Main information :
- The breach was discovered after a hacker boasted about stealing millions of data pieces from 23andMe on an online platform.
- 23andMe has been actively collaborating with federal law enforcement and forensic experts to delve deeper into the matter.
- The company has communicated to its users that unauthorized access was gained to certain accounts linked via the "DNA Relatives" feature.
- Post the revelation of this breach, there's been a surge in concerns among users about the potential misuse of their ethnicity and other sensitive data.
- 23andMe has temporarily disabled certain features in the "DNA Relatives" section to prioritize user privacy during this investigation.
FAQs
Our frequently questions
No items found.
Find out how iliomad can help your company.
[Map placeholder]
Only visible in production
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
October 28, 2026
Healthtech
Data Breach & Cybersecurity
GDPR
Regulation
LLMS
Healthcare AI Agents, Vendor Breaches and GDPR Reforms: Weekly Privacy and Regulation Digest
This week's digest covers autonomous AI agent risks, a wave of US healthcare vendor breaches, the EU Digital Omnibus GDPR mandate and Swiss voice-biometric enforcement.
October 26, 2026
GDPR
DPIA
Health Data Strategy
Regulations & Guidelines
Regulation
Clinical study protocol data protection: a practical guide for sponsors
Learn how to embed GDPR-compliant data protection into your clinical study protocol. Practical guidance on Section 13, DPIAs, transfers and local formalities.
October 23, 2026
Regulations & Guidelines
Clinical Trials
Regulation
Consent Forms
Big Data
Clinical Site Agreement: Navigating US Export Control Review of Cross-Border Data Transfers in Clinical Trials
Learn how institutional export control policies at clinical sites affect cross-border data transfers in trials, even below DOJ Bulk Data Rule thresholds.
